-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca's Enhertu Receives EU Approval Recommendation To Treat Unresectable Or Metastatic HER2-Positive Breast Cancer

Benzinga·07/24/2026 11:50:55
Listen to the news

https://mfn.se/cis/a/astrazeneca/astrazeneca-enhertu-plus-pertuzumab-recommended-for-approval-in-the-eu-by-chmp-as-1st-line-treatment-for-patients-with-her2-positive-metastatic-breast-cancer-56706f25